Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR

NCT04451668 is registered in ClinicalTrials.gov with Avadel as lead sponsor.

NCT NCT04451668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04451668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Lead sponsor
Avadel
Phase
Phase 3
Overall status
Completed
Start date
June 12, 2020
Completion date
November 18, 2024
Enrollment
184 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

cataplexy, excessive daytime somnolence, narcolepsy, sleep disorder, sleep disturbance, sleep wake disorders